Superiority of 3 over 2 doses of intermittent preventive treatment wWith sulfadoxine- pyrimethamine for the prevention of malaria during pregnancy in Mali: a randomized controlled trial

Autor: Oumou S Maïga, Diakite, Oumou M, Maiga, Kassoum, Kayentao, Boubacar T, Traoré, Abdoulaye, Djimde, Bouyagui, Traoré, Mouctar, Diallo, Mouctar, Traoré, Aissata, Ongoiba, Didier, Doumtabé, Safiatou, Doumbo, Mamadou S, Traoré, Antoine, Dara, Oumar, Guindo, Diawara M, Karim, Siraman, Coulibaly, Flabou, Bougoudogo, Feiko O, Ter Kuile, Martin, Danis, Ogobara K, Doumbo

Publikováno v: Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2011, 53 (3), pp.215-223. ⟨10.1093/cid/cir374⟩
Clinical infectious diseases, 53(3), 215-223. Oxford University Press

In 2003, Mali introduced intermittent preventive therapy in pregnancy (ITPp) with sulfadoxine-pyrimethamine (SP) for the control of malaria in pregnancy, consisting of 2 doses of SP given in the 2nd and 3rd trimester. This widely used regimen, althou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac3e8c6ef3080be3a942491b9b587e7
https://halshs.archives-ouvertes.fr/halshs-00681278